The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description
Louise M. Paterson, Remy S.A. Flechais, Anna Murphy, Laurence J. Reed, Sanja Abbott, Venkataramana Boyapati, Rebecca Elliott, David Erritzoe, Karen D. Ersche, Yetunde Faluyi, Luca Faravelli, Emilio Fernandez-Egea, Nicola J. Kalk, Shankar S. Kuchibatla, John McGonigle, Antonio Metastasio, Inge Mick, Liam Nestor, Csaba Orban, Filippo PassettiEugenii A. Rabiner, Dana G. Smith, John Suckling, Roger Tait, Eleanor M. Taylor, Adam D. Waldman, Trevor W. Robbins, Jf William Deakin, David J. Nutt*, Anne R. Lingford-Hughes
Research output: Contribution to journal › Article › peer-review
27Citations
(SciVal)
Fingerprint
Dive into the research topics of 'The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description'. Together they form a unique fingerprint.